<DOC>
	<DOC>NCT00941798</DOC>
	<brief_summary>Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.</brief_summary>
	<brief_title>Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Patients with a documented diagnosis of persistent asthma and who were currently treated with or qualified for treatment with both ICS and longacting beta2agonist (LABA) combination Patients demonstrating an increase in forced expiration volume in 1 second (FEV1) of ≥ 12% or ≥ 200 mLs within 30 minutes after administration of shortacting beta2agonist (SABA) Patients with an FEV1 ≥ 50% of predicted normal Patients with a previous diagnosis of chronic obstructive pulmonary disease (COPD) Patients who had an asthma attack/exacerbation requiring hospitalization/emergency room visit or respiratory tract infection within 1 month prior to randomization Patients who had ever required ventilator support for respiratory failure Patients with diabetes Type I or uncontrolled diabetes Type II Patients with concomitant pulmonary disease Patients with certain cardiovascular comorbid conditions Patients with any significant medical condition that might compromise patient safety, interfere with evaluation or preclude completion of the study Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>LABA</keyword>
	<keyword>Safety</keyword>
</DOC>